E
Effie W. Petersdorf
Researcher at Fred Hutchinson Cancer Research Center
Publications - 242
Citations - 20326
Effie W. Petersdorf is an academic researcher from Fred Hutchinson Cancer Research Center. The author has contributed to research in topics: Transplantation & Human leukocyte antigen. The author has an hindex of 67, co-authored 234 publications receiving 18917 citations. Previous affiliations of Effie W. Petersdorf include University of Oxford & National Taiwan University.
Papers
More filters
Journal ArticleDOI
Nomenclature for factors of the HLA system, 2010.
Steven G.E. Marsh,E. D. Albert,Walter F. Bodmer,Ronald E. Bontrop,Bo Dupont,Henry A. Erlich,Marcelo Fernandez-Vina,Daniel E. Geraghty,Rhonda Holdsworth,Carolyn Katovich Hurley,M. Lau,Keun-Seok Lee,Bernard Mach,Martin Maiers,Wolfgang R. Mayr,Carlheinz Müller,Peter Parham,Effie W. Petersdorf,Takehiko Sasazuki,Jack L. Strominger,A. Svejgaard,Paul I. Terasaki,Jean-Marie Tiercy,John Trowsdale +23 more
TL;DR: This report documents the additions and revisions to the nomenclature of HLA specificities following the principles established in previous reports.
Journal ArticleDOI
High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation.
Stephanie J. Lee,John P. Klein,Michael Haagenson,Lee Ann Baxter-Lowe,Dennis L. Confer,Mary Eapen,Marcelo Fernandez-Vina,Neal Flomenberg,Mary M. Horowitz,Carolyn Katovich Hurley,Harriet Noreen,Machteld Oudshoorn,Effie W. Petersdorf,Michelle Setterholm,Stephen R. Spellman,Daniel J. Weisdorf,Thomas M. Williams,Claudio Anasetti +17 more
TL;DR: In multivariate modeling, patient age, race, disease stage, and cytomegalovirus status were as predictive of survival as donor HLA matching, and high-resolution DNA matching for HLA-A, -B, -C, and -DRB1 alleles is associated with higher rates of survival.
Journal ArticleDOI
Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome.
Neal Flomenberg,Lee Ann Baxter-Lowe,Dennis L. Confer,Marcelo Fernandez-Vina,Alexandra H. Filipovich,Mary M. Horowitz,Carolyn Katovich Hurley,Craig Kollman,Claudio Anasetti,Harriet Noreen,Ann B. Begovich,William H. Hildebrand,Effie W. Petersdorf,B.J. Schmeckpeper,Michelle Setterholm,Elizabeth Trachtenberg,Thomas N. Williams,Edmond J. Yunis,Daniel J. Weisdorf +18 more
TL;DR: It is concluded that matching for HLA-C should be incorporated into algorithms for unrelated donor selection, and when clinical circumstances allow, high-resolution class I typing may help optimize donor selection and improve outcome.
Journal ArticleDOI
Bone Marrow Transplants from Unrelated Donors for Patients with Chronic Myeloid Leukemia
John A. Hansen,Ted Gooley,Paul J. Martin,Frederick R. Appelbaum,Thomas R. Chauncey,Reginald A. Clift,Effie W. Petersdorf,Jerald P. Radich,Jean E. Sanders,Rainer Storb,Keith M. Sullivan,Claudio Anasetti +11 more
TL;DR: Transplantation of marrow from an HLA-matched, unrelated donor is safe and effective therapy for selected patients with chronic myeloid leukemia.
Journal ArticleDOI
Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria
Mary E.D. Flowers,Yoshihiro Inamoto,Paul A. Carpenter,Stephanie J. Lee,Hans-Peter Kiem,Effie W. Petersdorf,Shalini E. Pereira,Richard A. Nash,Marco Mielcarek,Matthew L. Fero,Edus H. Warren,Jean E. Sanders,Rainer Storb,Frederick R. Appelbaum,Barry E. Storer,Barry E. Storer,Paul J. Martin +16 more
TL;DR: The results suggest that the mechanisms involved in acute and chronic GVHD are not entirely congruent and that chronicGVHD is not simply the end stage of acute GV HD.